Xenothera
About:
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.
Website: http://www.xenothera.com/
Top Investors: Bpifrance, European Innovation Council, EIC Accelerator, EASME - EU Executive Agency for SMEs, Starquest Capital
Description:
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases. Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera. Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.
26.5M EUR
Less than $1M
Nantes, Pays de la Loire, France
2014-01-01
contact(AT)xenothera.com
Jean-Paul Soulillou, Odile Duvaux
1-10
2021-06-29
Private
© 2025 bioDAO.ai